News & Updates

Show Multimedia Only

HRT use tied to reduced COVID-19 death risk

02 Jun 2022 by

The use of hormonal replacement therapy (HRT) among postmenopausal women may be associated with a reduced risk of mortality after a COVID-19 diagnosis, according to a retrospective study from Sweden.

02 Jun 2022

Postjab nAb assessment at one’s fingertips

01 Jun 2022 by

A group of researchers from Singapore has recently developed a finger stick blood test that can rapidly and semi-quantitatively assess the neutralizing antibody (nAb) response of people who have been vaccinated against COVID-19.

01 Jun 2022

Monkeypox scare grips countries

31 May 2022 by

Cases of the rare monkeypox viral disease have been detected in at least 12 countries and experts are cautiously concerned about yet another health disaster.

31 May 2022

Unvaccinated, Omicron-infected individuals vulnerable to reinfection

31 May 2022 by

Unvaccinated individuals show only very weak antibody responses to Omicron infection and may be susceptible to reinfection, while vaccinated individuals develop robust and broadly reactive antibody responses against SARS-CoV-2 variants, researchers from the University of Hong Kong (HKU) and the Chinese University of Hong Kong (CUHK) have reported.

31 May 2022

Original New Drug Application Approvals by US FDA (16 - 31 May 2022

31 May 2022

New drug applications approved by US FDA as of 16-31 May 2022 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

31 May 2022

MS patients on certain DMTs may have limited protection from COVID-19 vax

30 May 2022 by

The overall rate of hospitalization for COVID-19 is low among patients with multiple sclerosis (MS) treated with disease-modifying therapies (DMTs) who have been vaccinated against COVID-19, according to a prospective study from England. However, patients on ocrelizumab or fingolimod have elevated hospitalization rates.

30 May 2022

$BLU-5937 may SOOTHE refractory cough$

BLU-5937 may SOOTHE refractory cough

30 May 2022 by

Individuals with refractory chronic cough (RCC) may find relief in BLU-5937, a selective P2X3 antagonist under development which showed favourable efficacy in reducing cough frequency in the phase IIb SOOTHE trial.

30 May 2022

COVID-19 jabs help reduce long-term symptoms

27 May 2022 by

COVID-19 vaccination appears to reduce the odds of long COVID symptoms, with continuous improvement following a second dose, at least in the first few months after the shot, suggests a study.

27 May 2022

Infants with late-onset GBS develop sepsis, meningitis

27 May 2022

Sepsis or septic shock and bacterial meningitis, which are associated with non-negligible morbidity and mortality, frequently occur in infants with group B Streptococcus (GBS) late-onset disease (LOD), reports a recent study.

27 May 2022

Tuberculosis common in CKD patients

27 May 2022

Patients with chronic kidney disease (CKD) appears to have a high incidence of tuberculosis, with regional disparities, according to a study.

27 May 2022

News & Updates

Showing Infectious Diseases articles

Showing

Specialty:

HRT use tied to reduced COVID-19 death risk

Postjab nAb assessment at one’s fingertips

Monkeypox scare grips countries

Unvaccinated, Omicron-infected individuals vulnerable to reinfection

Original New Drug Application Approvals by US FDA (16 - 31 May 2022

MS patients on certain DMTs may have limited protection from COVID-19 vax

BLU-5937 may SOOTHE refractory cough

COVID-19 jabs help reduce long-term symptoms

Infants with late-onset GBS develop sepsis, meningitis

Tuberculosis common in CKD patients